Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease.
about
Serine racemase: a key player in apoptosis and necrosisParkinson's disease: animal models and dopaminergic cell vulnerabilityGlucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease.Genetic deletion of the Histone Deacetylase 6 exacerbates selected behavioral deficits in the R6/1 mouse model for Huntington's disease.Hippocampal α-synuclein and interneurons in Parkinson's disease: Data from human and mouse models.Alpha-synuclein spreading in M83 mice brain revealed by detection of pathological α-synuclein by enhanced ELISA.Motor and cognitive deficits in aged tau knockout mice in two background strains.Validation and implementation of a novel high-throughput behavioral phenotyping instrument for mice.Splicing landscape of the eight collaborative cross founder strains.Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant α-synuclein.Postnatal Erythropoietin Mitigates Impaired Cerebral Cortical Development Following Subplate Loss from Prenatal Hypoxia-Ischemia.Neurobiology of rodent self-grooming and its value for translational neuroscienceFasudil attenuates aggregation of α-synuclein in models of Parkinson's diseaseInteraction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitisPreliminary Evidence of Apathetic-Like Behavior in Aged Vesicular Monoamine Transporter 2 Deficient Mice.MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.Animal models of α-synucleinopathy for Parkinson disease drug development.Effects of GABAa receptor antagonists on motor behavior in pharmacological Parkinson's disease model in mice.Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP.Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington's diseaseReply to Konsolaki and Skaliora: Habituation, hyperlocomotion, and "genuine hyperlocomotion".α-Synuclein staging in the amygdala of a Parkinson's disease model: cell types involved.Neuroprotective effect of chondroitin sulfate on SH‑SY5Y cells overexpressing wild‑type or A53T mutant α‑synuclein.Gclc deficiency in mouse CNS causes mitochondrial damage and neurodegeneration.Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders.Behavioral characterization of striatal-enriched protein tyrosine phosphatase (STEP) knockout mice.'Prion-like' propagation of the synucleinopathy of M83 transgenic mice depends on the mouse genotype and type of inoculum.p62 Deficiency Enhances α-Synuclein Pathology in Mice.Inhibition of glucosylceramide synthase stimulates autophagy flux in neurons.Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy.Locomotor differences in mice expressing wild-type human α-synuclein.Salidroside Promotes the Pathological α-Synuclein Clearance Through Ubiquitin-Proteasome System in SH-SY5Y Cells.NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson's Disease.
P2860
Q27025560-CF66EC30-86A6-447B-9C2B-C1B4EE932E41Q28080503-5E76C5AD-E4B9-4E20-BBB7-E7C65F704212Q30367337-6A1BF43D-92A6-496C-9F5D-031A98D61B95Q30401432-45B57E02-C860-42BD-AF2B-1A9445202B7FQ31060511-F3C888FE-E31A-4852-A0ED-831E27C7D0A8Q33557077-82B01F16-76DD-4A77-9672-295299E045C1Q34077327-B89FFDD1-5CFB-431F-AB3B-4685907CE515Q35009299-5024E64D-D51A-4443-B614-97313163641DQ35061346-C83F6CD7-F822-4307-8439-BB63C1C0415EQ35158376-AD2232C4-9402-41D4-A8A3-E8CFD58C8C26Q35208334-AECFB6A6-FF7E-45BD-89B8-DD2C5948265CQ35956626-5EDE1711-55BD-48F1-927E-3B58FEAF7D33Q36825003-BD767358-6EBA-45A1-9AE1-B654A6DCF257Q36825541-45A80D88-2F94-4D4A-9A17-75D616714CA4Q37228420-C6106B1D-8CD8-4979-9F72-880B5CBD7D74Q37421148-950AB396-7B8C-4171-BE8D-EC1A3B33BECAQ37702119-A13281D3-B573-4A3A-91E9-D8D5A190FDC2Q38669105-35869508-C307-4109-8AA2-7BD360242717Q40106906-52DA7F99-490D-42BB-AB93-23AF0846F116Q41928667-0A28C3BF-C405-4606-93B7-0475F0E17E57Q42483926-E5DF9370-6B85-4F1E-A984-17B10982041AQ42577971-086DF5C5-4600-417C-8493-04EC9B706E89Q43102716-59901016-ACD6-47F9-AC96-4C15529036A9Q44281222-7D7EA174-AC65-4E46-B98E-3FFB2AC67E2DQ46291421-012E5118-36F3-43B8-BAD8-31AABD3CCD24Q46423514-9E3C23D6-E269-4ED6-88CB-BA25FA973442Q47619917-0DA705D8-6DA7-45B1-BEFD-AF1AEA61D506Q47741961-E95A55CC-5327-47A0-A3C8-A9F364A9C338Q47995205-F21F5652-7627-4CFD-A913-6E529F392331Q48451250-B58AFC32-D033-4D94-8BA9-9D9D3C3E286AQ51754932-734D0639-31D5-45CD-AE4D-E57DFF815C8CQ51762778-39042030-E36F-46A8-9D09-F0699BB25A8DQ51767457-B13FC0D7-5939-402F-A49A-949EDB992325Q55080796-317D5454-0148-4093-8549-BA3D477F7B38Q55512119-87C16BC6-4ADE-47AA-8D8C-B1E7964FCAB9
P2860
Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Behavioral characterization of ...... related to Parkinson's disease
@nl
Behavioral characterization of ...... elated to Parkinson's disease.
@ast
Behavioral characterization of ...... elated to Parkinson's disease.
@en
type
label
Behavioral characterization of ...... related to Parkinson's disease
@nl
Behavioral characterization of ...... elated to Parkinson's disease.
@ast
Behavioral characterization of ...... elated to Parkinson's disease.
@en
prefLabel
Behavioral characterization of ...... related to Parkinson's disease
@nl
Behavioral characterization of ...... elated to Parkinson's disease.
@ast
Behavioral characterization of ...... elated to Parkinson's disease.
@en
P2093
P2860
P3181
P1433
P1476
Behavioral characterization of ...... related to Parkinson's disease
@en
P2093
Cathleen Gonzales
Dmytro Vasilyev
Edward Kaftan
John Dunlop
Katrina L Paumier
Margaret Zaleska
Michael Monaghan
Polina Stolyar
Susan Lotarski
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0070274
P407
P577
2013-08-01T00:00:00Z